Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia. (Q33403052)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia. (English)

1 reference

Europe PubMed Central

26 July 2017

thrombocytopenia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Nicola Polverelli

6

object named as

Nicola Polverelli

1 reference

Europe PubMed Central

26 July 2017

object named as

Lucia Catani

1

0 references

Francesca Palandri

object named as

Francesca Palandri

7

0 references

Michele Baccarani

8

object named as

Michele Baccarani

1 reference

Europe PubMed Central

26 July 2017

2

object named as

Daria Sollazzo

1 reference

Europe PubMed Central

26 July 2017

Roberto Massimo Lemoli

10

object named as

Roberto Massimo Lemoli

1 reference

Europe PubMed Central

26 July 2017

Sara Trabanelli

3

object named as

Sara Trabanelli

1 reference

Europe PubMed Central

26 July 2017

author name string

Antonio Curti

4

1 reference

Europe PubMed Central

26 July 2017

Cecilia Evangelisti

5

1 reference

Europe PubMed Central

26 July 2017

Nicola Vianelli

9

1 reference

Europe PubMed Central

26 July 2017

publication date

31 August 2012

1 reference

Europe PubMed Central

26 July 2017

Annals of Hematology

1 reference

Europe PubMed Central

26 July 2017

92

1 reference

Europe PubMed Central

26 July 2017

67-78

1 reference

Europe PubMed Central

26 July 2017

1

1 reference

Europe PubMed Central

26 July 2017

How do regulatory T cells work?

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Phenotypical and functional specialization of FOXP3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

How tolerogenic dendritic cells induce regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

CTLA-4-Ig regulates tryptophan catabolism in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Impaired indoleamine 2,3-dioxygenase production contributes to the development of autoimmunity in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

The pathogenesis of chronic immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

The ITP syndrome: pathogenic and clinical diversity

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

ITP: a historical perspective

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Recent progress in understanding the pathogenesis of immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

International consensus report on the investigation and management of primary immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Biology of interleukin-10.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Regulatory T cells and immune tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Human regulatory T cells in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Modulation of dendritic cell function by naive and regulatory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

The CD47 pathway is deregulated in human immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

De novo induction of platelet-specific CD4(+)CD25(+) regulatory T cells from CD4(+)CD25(-) cells in patients with idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Decreased IDO activity and increased TTS expression break immune tolerance in patients with immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

The Family of IL-10-secreting CD4+ T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Immunomodulation by semi-mature dendritic cells: a novel role of Toll-like receptors and interleukin-6.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1556-5

21 January 2018

Identifiers

10.1007/S00277-012-1556-5

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33403052&oldid=1854468305"